Director's Publications

Quantifying risk factors to guide progress towards leprosy elimination.Pandey A, Galvani AP. Lancet Glob Health. 2019 Sep; 2019 Jul 19. PMID: 31331812.
The global burden of HIV and prospects for control.Pandey A, Galvani AP. Lancet HIV. 2019 Aug 19; 2019 Aug 19. PMID: 31439533.
What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?Bartsch SM, Asti L, Cox SN, Durham DP, Randall S, Hotez PJ, Galvani AP, Lee BY. J Infect Dis. 2019 Aug 9. PMID: 30544164.
Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL. Clin Infect Dis. 2019 May 30; 2019 May 30. PMID: 31143944.
Ebola vaccination in the Democratic Republic of the Congo.Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2019 May 14; 2019 Apr 29. PMID: 31036657.
Metrics and benchmarks for HIV transition - Authors' reply.Pandey A, Fitzpatrick MC, Galvani AP. Lancet HIV. 2019 Mar. PMID: 30846055.
Harnessing synergies at the interface of public health and the security sector.Thomson N, Littlejohn M, Strathdee SA, Southby RF, Coghlan B, Rosenfeld JV, Galvani AP. Lancet. 2019 Jan 19. PMID: 30663581.
Resolving the apparent transmission paradox of African sleeping sickness.Capewell P, Atkins K, Weir W, Jamonneau V, Camara M, Clucas C, Swar NK, Ngoyi DM, Rotureau B, Garside P, Galvani AP, Bucheton B, MacLeod A. PLoS Biol. 2019 Jan; 2019 Jan 11. PMID: 30633739.
The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission.Bartsch SM, Avelis CM, Asti L, Hertenstein DL, Ndeffo-Mbah M, Galvani A, Lee BY. PLoS Negl Trop Dis. 2018 Nov; 2018 Nov 5. PMID: 30395603.
Defining control of HIV epidemics.Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE. Lancet HIV. 2018 Nov; 2018 Oct 9. PMID: 30314745.
Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP. Lancet HIV. 2018 Sep; 2018 Jun 13. PMID: 29908917.
The Challenge of Vanquishing HIV for the Next Generation-Facing the Future.Fitzpatrick MC, Gray GE, Galvani AP. JAMA Pediatr. 2018 Jul 1. PMID: 29800028.
Policy Lessons From Quantitative Modeling of Leprosy.Medley GF, Blok DJ, Crump RE, Hollingsworth TD, Galvani AP, Ndeffo-Mbah ML, Porco TC, Richardus JH. Clin Infect Dis. 2018 Jun 1. PMID: 29860289.
Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling.Rock KS, Ndeffo-Mbah ML, Castaño S, Palmer C, Pandey A, Atkins KE, Ndung'u JM, Hollingsworth TD, Galvani A, Bever C, Chitnis N, Keeling MJ. Clin Infect Dis. 2018 Jun 1. PMID: 29860287.
Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. Epidemiol Rev. 2018 Jun 1. PMID: 29566137.
Optimizing the impact of low-efficacy influenza vaccines.Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2018 May 15; 2018 Apr 30. PMID: 29712866.
Evaluating Vaccination Strategies for Zika Virus in the Americas.Durham DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, Michael NL, Galvani AP. Ann Intern Med. 2018 May 1; 2018 Apr 3. PMID: 29610863.
Spatial distribution of leprosy in India: an ecological study.Grantz KH, Chabaari W, Samuel RK, Gershom B, Blum L, Worden L, Ackley S, Liu F, Lietman TM, Galvani AP, Prajna L, Porco TC. Infect Dis Poverty. 2018 Mar 27; 2018 Mar 27. PMID: 29580296.
Are the London Declaration's 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula.Lee BY, Bartsch SM, Skrip L, Hertenstein DL, Avelis CM, Ndeffo-Mbah M, Tilchin C, Dumonteil EO, Galvani A. PLoS Negl Trop Dis. 2018 Mar; 2018 Mar 19. PMID: 29554086.
Underestimation of the global burden of schistosomiasis.King CH, Galvani AP. Lancet. 2018 Jan 27; 2018 Jan 31. PMID: 29413041.
Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee.Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP. Lancet. 2017 Nov 25; 2017 Jun 29. PMID: 28669643.
HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.Sah P, Fitzpatrick MC, Pandey A, Galvani AP. AIDS. 2017 Nov 13. PMID: 29068837.
California Universal Health Care Bill: an economic stimulus and life-saving proposal.Galvani AP, Durham DP, Vermund SH, Fitzpatrick MC. Lancet. 2017 Oct 28; 2017 Sep 17. PMID: 28923467.
Fund global health: Save lives and money.Galvani AP, Fitzpatrick MC, Vermund SH, Singer BH. Science. 2017 Jun 9. PMID: 28596330.
Characterizing risk of Ebola transmission based on frequency and type of case-contact exposures.Skrip LA, Fallah MP, Gaffney SG, Yaari R, Yamin D, Huppert A, Bawo L, Nyenswah T, Galvani AP. Philos Trans R Soc Lond B Biol Sci. 2017 May 26. PMID: 28396472.
Assessing real-time Zika risk in the United States.Castro LA, Fox SJ, Chen X, Liu K, Bellan SE, Dimitrov NB, Galvani AP, Meyers LA. BMC Infect Dis. 2017 May 4; 2017 May 4. PMID: 28468671.
The potential economic burden of Zika in the continental United States.Lee BY, Alfaro-Murillo JA, Parpia AS, Asti L, Wedlock PT, Hotez PJ, Galvani AP. PLoS Negl Trop Dis. 2017 Apr; 2017 Apr 27. PMID: 28448488.
Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.Brock AR, Ross JV, Greenhalgh S, Durham DP, Galvani A, Parikh S, Esterman A. Infect Dis Model. 2017 May; 2017 Apr 15. PMID: 29928735.
Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.Alsallaq RA, Gurarie D, Ndeffo Mbah M, Galvani A, King C. PLoS Negl Trop Dis. 2017 Apr; 2017 Apr 14. PMID: 28410369.
Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Proc Natl Acad Sci U S A. 2017 Apr 11; 2017 Mar 20. PMID: 28320938.
Global elimination of lymphatic filariasis.Ndeffo-Mbah ML, Galvani AP. Lancet Infect Dis. 2017 Apr; 2016 Dec 22. PMID: 28012944.
Forecasting the new case detection rate of leprosy in four states of Brazil: A comparison of modelling approaches.Blok DJ, Crump RE, Sundaresh R, Ndeffo-Mbah M, Galvani AP, Porco TC, de Vlas SJ, Medley GF, Richardus JH. Epidemics. 2017 Mar. PMID: 28279460.
Comparison and validation of two computational models of Chagas disease: A thirty year perspective from Venezuela.Bartsch SM, Peterson JK, Hertenstein DL, Skrip L, Ndeffo-Mbah M, Galvani AP, Dobson AP, Lee BY. Epidemics. 2017 Mar. PMID: 28279459.
Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis.Fallah MP, Skrip LA, Raftery P, Kullie M, Borbor W, Laney AS, Blackley DJ, Christie A, Dokubo EK, Lo TQ, Coulter S, Baller A, Vonhm BT, Bemah P, Lomax S, Yeiah A, Wapoe-Sackie Y, Mann J, Clement P, Davies-Wayne G, Hamblion E, Wolfe C, Williams D, Gasasira A, Kateh F, Nyenswah TG, Galvani AP. PLoS Med. 2017 Jan; 2017 Jan 24. PMID: 28118353.
Strategies for Trypanosoma brucei gambiense elimination.Pandey A, Galvani A. Lancet Glob Health. 2017 Jan; 2016 Nov 21. PMID: 27884708.
One Health approach to cost-effective rabies control in India.Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP. Proc Natl Acad Sci U S A. 2016 Dec 20. PMID: 27994161.
Human-environment interactions in population and ecosystem health.Galvani AP, Bauch CT, Anand M, Singer BH, Levin SA. Proc Natl Acad Sci U S A. 2016 Dec 20; 2016 Dec 12. PMID: 27956616.
Philippine drug war and impending public health crisis.Macarayan E, Ndeffo-Mbah M, Beyrer C, Galvani AP. Lancet. 2016 Dec 10. PMID: 27979404.
Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs.Schlüter DK, Ndeffo-Mbah ML, Takougang I, Ukety T, Wanji S, Galvani AP, Diggle PJ. PLoS Negl Trop Dis. 2016 Dec; 2016 Dec 1. PMID: 27906982.
Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa.Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. PLoS One. 2016; 2016 Dec 1. PMID: 27906986.
Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa.Bilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP. Proc Biol Sci. 2016 Nov 16. PMID: 27852799.
Vaccination strategies against respiratory syncytial virus.Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, Galvani AP. Proc Natl Acad Sci U S A. 2016 Nov 15; 2016 Oct 31. PMID: 27799521.
Mitigating Prenatal Zika Virus Infection in the Americas.Ndeffo-Mbah ML, Parpia AS, Galvani AP. Ann Intern Med. 2016 Oct 18; 2016 Jul 26. PMID: 27454076.
Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease.Fallah MP, Skrip LA, Dahn BT, Nyenswah TG, Flumo H, Glayweon M, Lorseh TL, Kaler SG, Higgs ES, Galvani AP. Lancet Glob Health. 2016 Oct. PMID: 27633422.
Cross-Cultural Household Influence on Vaccination Decisions.Taylor E, Atkins KE, Medlock J, Li M, Chapman GB, Galvani AP. Med Decis Making. 2016 Oct; 2015 Jun 17. PMID: 26085600.
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, Hellard M, Beyrer C, Altice FL. Lancet. 2016 Sep 10; 2016 Jul 14. PMID: 27427453.
Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings.Skrip LA, Galvani AP. PLoS Negl Trop Dis. 2016 Aug; 2016 Aug 18. PMID: 27537602.
Stimulating Influenza Vaccination via Prosocial Motives.Li M, Taylor EG, Atkins KE, Chapman GB, Galvani AP. PLoS One. 2016; 2016 Jul 26. PMID: 27459237.
Disease Surveillance on Complex Social Networks.Herrera JL, Srinivasan R, Brownstein JS, Galvani AP, Meyers LA. PLoS Comput Biol. 2016 Jul; 2016 Jul 14. PMID: 27415615.
Cost-effectiveness of next-generation vaccines: The case of pertussis.Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP. Vaccine. 2016 Jun 17; 2016 Apr 14. PMID: 27087151.
Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States.Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. Am J Epidemiol. 2016 Jun 15; 2016 May 13. PMID: 27188951.
A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control.Alfaro-Murillo JA, Parpia AS, Fitzpatrick MC, Tamagnan JA, Medlock J, Ndeffo-Mbah ML, Fish D, Ávila-Agüero ML, Marín R, Ko AI, Galvani AP. PLoS Negl Trop Dis. 2016 May; 2016 May 20. PMID: 27205899.
National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States.Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. Proc Natl Acad Sci U S A. 2016 May 3; 2016 Apr 18. PMID: 27091978.
Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine.DeAngelis H, Scarpino SV, Fitzpatrick MC, Galvani AP, Althouse BM. JAMA Pediatr. 2016 May 1. PMID: 27018830.
Evaluating the effectiveness of localized control strategies to curtail chikungunya.Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP. Sci Rep. 2016 Apr 5; 2016 Apr 5. PMID: 27045523.
Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia.Atkins KE, Pandey A, Wenzel NS, Skrip L, Yamin D, Nyenswah TG, Fallah M, Bawo L, Medlock J, Altice FL, Townsend J, Ndeffo-Mbah ML, Galvani AP. Am J Trop Med Hyg. 2016 Apr; 2016 Feb 29. PMID: 26928839.
Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP. Emerg Infect Dis. 2016 Apr. PMID: 26982504.
Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis.Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP. PLoS Negl Trop Dis. 2016 Mar; 2016 Mar 8. PMID: 26954675.
Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives.Fallah M, Dahn B, Nyenswah TG, Massaquoi M, Skrip LA, Yamin D, Mbah MN, Joe N, Freeman S, Harris T, Benson Z, Galvani AP. Ann Intern Med. 2016 Mar 1; 2016 Jan 5. PMID: 26746879.
Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa.Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Emerg Infect Dis. 2016 Mar. PMID: 26886846.
Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.Eggo RM, Scott JG, Galvani AP, Meyers LA. Proc Natl Acad Sci U S A. 2016 Feb 23; 2016 Feb 8. PMID: 26858436.
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.Durham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, Townsend JP. Clin Infect Dis. 2016 Feb 1; 2015 Nov 30. PMID: 26628566.
Social contacts, vaccination decisions and influenza in Japan.Ibuka Y, Ohkusa Y, Sugawara T, Chapman GB, Yamin D, Atkins KE, Taniguchi K, Okabe N, Galvani AP. J Epidemiol Community Health. 2016 Feb; 2015 Sep 30. PMID: 26424846.
Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US.Alfaro-Murillo JA, Townsend JP, Galvani AP. Vaccine. 2016 Jan 4; 2015 Nov 27. PMID: 26631416.
Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection.Yamin D, Atkins KE, Remy V, Galvani AP. Value Health. 2016 Sep - Oct; 2016 Jul 15. PMID: 27712709.
Quantifying Poverty as a Driver of Ebola Transmission.Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP. PLoS Negl Trop Dis. 2015 Dec; 2015 Dec 31. PMID: 26720278.
Disease elimination and re-emergence in differential-equation models.Greenhalgh S, Galvani AP, Medlock J. J Theor Biol. 2015 Dec 21; 2015 Oct 22. PMID: 26471072.
Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases.Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Basáñez MG, Behrend M, Blok DJ, Chapman LA, Coffeng L, Courtenay O, Crump RE, de Vlas SJ, Dobson A, Dyson L, Farkas H, Galvani AP, Gambhir M, Gurarie D, Irvine MA, Jervis S, Keeling MJ, Kelly-Hope L, King C, Lee BY, Le Rutte EA, Lietman TM, Ndeffo-Mbah M, Medley GF, Michael E, Pandey A, Peterson JK, Pinsent A, Porco TC, Richardus JH, Reimer L, Rock KS, Singh BK, Stolk W, Swaminathan S, Torr SJ, Townsend J, Truscott J, Walker M, Zoueva A. Parasit Vectors. 2015 Dec 9; 2015 Dec 9. PMID: 26652272.
Public health impact of disease-behavior dynamics: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al.Wells CR, Galvani AP. Phys Life Rev. 2015 Dec; 2015 Oct 19. PMID: 26514411.
Impact of bed capacity on spatiotemporal shifts in Ebola transmission.Townsend JP, Skrip LA, Galvani AP. Proc Natl Acad Sci U S A. 2015 Nov 17; 2015 Oct 30. PMID: 26518509.
Spatial heterogeneity in projected leprosy trends in India.Brook CE, Beauclair R, Ngwenya O, Worden L, Ndeffo-Mbah M, Lietman TM, Satpathy SK, Galvani AP, Porco TC. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26490137.
Evaluating long-term effectiveness of sleeping sickness control measures in Guinea.Pandey A, Atkins KE, Bucheton B, Camara M, Aksoy S, Galvani AP, Ndeffo-Mbah ML. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26490037.
Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, Aurelio HO, Ferro J, Galvani AP, King CH. Parasit Vectors. 2015 Oct 22; 2015 Oct 22. PMID: 26489408.
Spatial and Temporal Clustering of Chikungunya Virus Transmission in Dominica.Nsoesie EO, Ricketts RP, Brown HE, Fish D, Durham DP, Ndeffo Mbah ML, Christian T, Ahmed S, Marcellin C, Shelly E, Owers K, Wenzel N, Galvani AP, Brownstein JS. PLoS Negl Trop Dis. 2015; 2015 Aug 14. PMID: 26274813.
Strategies to prevent future Ebola epidemics.Fallah M, Skrip LA, d'Harcourt E, Galvani AP. Lancet. 2015 Jul 11. PMID: 26194388.
Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola.Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. PLoS Negl Trop Dis. 2015 Jun; 2015 Jun 24. PMID: 26107520.
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. Lancet Infect Dis. 2015 Jun; 2015 Apr 14. PMID: 25886798.
Harnessing case isolation and ring vaccination to control Ebola.Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. PLoS Negl Trop Dis. 2015 May; 2015 May 29. PMID: 26024528.
Effect of Ebola progression in Liberia.Yamin D, Gertler S, Ndeffo-Mbah ML, Galvani AP. Ann Intern Med. 2015 May 19. PMID: 25984855.
Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa.Gilbert JA, Long EF, Brooks RP, Friedland GH, Moll AP, Townsend JP, Galvani AP, Shenoi SV. PLoS One. 2015; 2015 May 4. PMID: 25938501.
Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission.Scarpino SV, Iamarino A, Wells C, Yamin D, Ndeffo-Mbah M, Wenzel NS, Fox SJ, Nyenswah T, Altice FL, Galvani AP, Meyers LA, Townsend JP. Clin Infect Dis. 2015 Apr 1; 2014 Dec 15. PMID: 25516185.
Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.Gutfraind A, Galvani AP, Meyers LA. JAMA Pediatr. 2015 Apr. PMID: 25706618.
Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.Bellan SE, Dushoff J, Galvani AP, Meyers LA. PLoS Med. 2015 Mar; 2015 Mar 17. PMID: 25781323.
Under-reporting and case fatality estimates for emerging epidemics.Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. BMJ. 2015 Mar 16; 2015 Mar 16. PMID: 25779635.
Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa.Ndeffo Mbah ML, Parikh S, Galvani AP. Am J Trop Med Hyg. 2015 Mar; 2015 Jan 26. PMID: 25624402.
Nine challenges in incorporating the dynamics of behaviour in infectious diseases models.Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, Galvani AP, Klepac P. Epidemics. 2015 Mar; 2014 Sep 28. PMID: 25843377.
The epidemiological impact of HIV antiretroviral therapy on malaria in children.Greenhalgh S, Ndeffo M, Galvani AP, Parikh S. AIDS. 2015 Feb 20. PMID: 25486414.
Optimizing distribution of pandemic influenza antiviral drugs.Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA. Emerg Infect Dis. 2015 Feb. PMID: 25625858.
Effect of Ebola progression on transmission and control in Liberia.Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP. Ann Intern Med. 2015 Jan 6. PMID: 25347321.
Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis.Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP. Lancet Infect Dis. 2014 Dec; 2014 Oct 23. PMID: 25455986.
Strategies for containing Ebola in West Africa.Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP. Science. 2014 Nov 21; 2014 Oct 30. PMID: 25414312.
Ebola vaccination: if not now, when?Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE. Ann Intern Med. 2014 Nov 18. PMID: 25141813.
Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa.Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP. PLoS Negl Trop Dis. 2014 Oct; 2014 Oct 16. PMID: 25329403.
Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel.Yamin D, Balicer RD, Galvani AP. Vaccine. 2014 Jul 16; 2014 Jun 12. PMID: 24930716.
Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.Ndeffo Mbah ML, Gilbert JA, Galvani AP. Epidemics. 2014 Jun; 2014 Apr 29. PMID: 24928666.
How inexpensive does an alcohol intervention in Kenya need to be in order to deliver favorable value by reducing HIV-related morbidity and mortality?Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Li L, Mentor SM, Uhler LM, Roberts MS, Galvani A, Bryant K. J Acquir Immune Defic Syndr. 2014 Jun 1. PMID: 24828269.
An innovative influenza vaccination policy: targeting last season's patients.Yamin D, Gavious A, Solnik E, Davidovitch N, Balicer RD, Galvani AP, Pliskin JS. PLoS Comput Biol. 2014 May; 2014 May 22. PMID: 24851863.
Ethical alternatives to experiments with novel potential pandemic pathogens.Lipsitch M, Galvani AP. PLoS Med. 2014 May; 2014 May 20. PMID: 24844931.
Cellular superspreaders: an epidemiological perspective on HIV infection inside the body.Talbert-Slagle K, Atkins KE, Yan KK, Khurana E, Gerstein M, Bradley EH, Berg D, Galvani AP, Townsend JP. PLoS Pathog. 2014 May; 2014 May 8. PMID: 24811311.
A marginal benefit approach for vaccinating influenza "superspreaders".Skene KJ, Paltiel AD, Shim E, Galvani AP. Med Decis Making. 2014 May. PMID: 24740238.